Pennant group chief clinical officer sells $53,699 in stock
Pennant Group's Chief Clinical Officer, Jason Paul Steik, recently sold 1,394 shares of company stock for a total of $53,699. This transaction follows strong stock performance, with PNTG shares up 55.66% over the past year and 39.68% year-to-date, although the stock appears overvalued according to InvestingPro analysis. The company also recently reported strong Q2 2026 financial results, surpassing analyst expectations, and received a raised price target from Wells Fargo.
Will Pennant’s Higher 2026 Guidance and Tucson Acquisition Change Pennant Group's (PNTG) Narrative
The Pennant Group reported strong Q2 2026 results, including increased sales and net income, and raised its 2026 revenue guidance to US$1.17 billion to US$1.19 billion. The company also expanded its senior living portfolio with the acquisition of River Centre Assisted Living in Tucson, Arizona. While these moves indicate growth, they also increase execution risk due to existing debt and thin profit margins, leading to mixed fair value estimates from analysts.
Will Pennant’s Higher 2026 Guidance and Tucson Acquisition Change Pennant Group's (PNTG) Narrative
The Pennant Group (PNTG) reported strong Q2 2026 results with increased sales and net income, along with higher 2026 revenue guidance of US$1.17 billion to US$1.19 billion. The company also expanded its senior living portfolio by acquiring the River Centre Assisted Living community in Tucson. This strategic move supports Pennant's growth narrative through network expansion, though it also introduces execution risk due to existing debt and thin profit margins.
Wasatch Advisors LP Raises Position in The Pennant Group, Inc. $PNTG
Wasatch Advisors LP increased its stake in The Pennant Group, Inc. (NASDAQ:PNTG) by 31.8% in the second quarter, bringing its total holdings to 1.87 million shares valued at $69.1 million. The company has a "Moderate Buy" consensus rating from analysts with an average price target of $41.20, and recently reported strong quarterly earnings that beat estimates. Despite positive indicators, shares opened down 3.7% at $38.17.
Renaissance Technologies LLC Decreases Stock Position in The Pennant Group, Inc. $PNTG
Renaissance Technologies LLC significantly reduced its stake in The Pennant Group, Inc. (NASDAQ:PNTG) by 43.8% in the first quarter, selling over 51,000 shares but still retaining a position valued at approximately $2.02 million. Despite this reduction, institutional investors collectively own a substantial 85.88% of PNTG. The company has received a "Moderate Buy" consensus rating from analysts with an average price target of $41.20, and recently surpassed quarterly earnings and revenue estimates.
Wells Fargo & Company Raises The Pennant Group (NASDAQ:PNTG) Price Target to $46.00
Wells Fargo & Company has increased its price target for The Pennant Group (NASDAQ:PNTG) to $46.00 from $45.00, maintaining an "overweight" rating. This new target implies a potential upside of 16.04% from the previous closing price. The company recently reported strong quarterly earnings, surpassing consensus estimates with $0.36 EPS and $297.98 million in revenue, contributing to a "Moderate Buy" consensus rating from analysts.
Wells Fargo raises Pennant Group stock price target on earnings outlook
Wells Fargo has increased its price target for The Pennant Group (NASDAQ:PNTG) to $46 from $45, maintaining an Overweight rating, citing raised adjusted EBITDAR estimates and strong same-store growth. The healthcare services company recently exceeded second-quarter 2026 earnings expectations, reporting adjusted earnings of $0.36 per share and revenue of $298.0 million, leading to a raised financial outlook despite a slight dip in stock price. The valuation is further supported by an improved reimbursement profile, especially in Home Health, and the positive impact of mergers and acquisitions.
Pennant Group (PNTG) Chief Clinical Officer sells 1,394 shares in Rule 10b5-1 trade
Pennant Group, Inc. (PNTG) Chief Clinical Officer Jason Paul Steik sold 1,394 shares of common stock at $38.522 per share on August 6, 2026, as reported in a Rule 10b5-1 trading plan transaction. Following this sale, Steik directly holds 15,106 shares of the company's common stock. The sale, valued at approximately $54,000, was filed on a Form 4.
Pennant Group (PNTG) CEO executes 4,285-share planned stock sale at $38.52
Pennant Group (PNTG) CEO Brent Guerisoli sold 4,285 shares of common stock on August 6, 2026, at an average price of $38.522 per share. This transaction was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on May 31, 2024. Following the sale, Guerisoli directly holds 99,544 shares of Pennant Group common stock.
Pennant Group Inc (PNTG) Stock News Today
This article provides recent news and financial data for Pennant Group Inc (PNTG). It highlights the company's current stock performance, market capitalization, P/E ratio, and recent earnings, specifically mentioning a 35.8% revenue growth in home health and hospice for Q2 2026. The article also lists categories for more detailed analysis available on the platform.
The Pennant Group Leverages Technology in Hospice Growth
The Pennant Group Inc. is investing in technology, particularly AI, to enhance its hospice and home health segment amidst growing demand and new regulatory changes. CEO Brent Guerisoli highlighted AI's role in boosting revenue, quality, and operational efficiency by reducing clinical documentation time and automating back-office processes. This technological adoption aims to increase clinical capacity and decrease administrative costs, ultimately leading to more effective and efficient care delivery.
What Pennant Group (PNTG)'s Q2 Beat, Guidance Hike and New Acquisition Means For Shareholders
The Pennant Group reported strong Q2 2026 results, surpassing revenue and net income expectations, and subsequently raised its full-year 2026 revenue guidance. This positive financial performance is further bolstered by the strategic acquisition of the 63-unit River Centre Assisted Living community, expanding its senior living footprint. The article suggests these developments reinforce the company's investment narrative centered on demographic trends and operational efficiency, although risks like reimbursement changes and labor costs persist.
The Pennant Group Leverages Technology in Hospice Growth
The Pennant Group (Nasdaq: PNTG) is heavily investing in technology, particularly AI, to enhance its hospice and home health operations, improve quality, and boost revenue. The company is piloting AI tools to streamline clinical documentation and back-office processes, aiming to increase clinical capacity and reduce administrative costs. This strategic focus comes as Pennant navigates rising demand and a complex regulatory environment, including new measures from CMS to combat fraud in the hospice industry.
The Pennant Group, Inc. $PNTG Shares Bought by Sei Investments Co.
Sei Investments Co. increased its stake in The Pennant Group, Inc. (NASDAQ:PNTG) by 33.7% in the first quarter, now holding 153,546 shares valued at $4.68 million. Other institutional investors have also adjusted their positions, with collective institutional ownership reaching 85.88%. The company reported strong Q1 earnings and revenue that surpassed analyst expectations, maintaining a "Moderate Buy" consensus rating among analysts with an average price target of $41.00.
Pennant Group sees ‘steady stream’ of senior living deals in second quarter
The Pennant Group reported a "steady stream" of senior living deals in the second quarter of 2026, including several acquisitions across Arizona, Wisconsin, and California. This growth led to a significant increase in senior living segment revenue and overall company revenue. The company is raising its annual guidance, driven by operational excellence and successful integration of acquired properties.
Proposed pay increase ‘a positive signal,’ Pennant CEO says as company reports second-quarter results
Pennant Group CEO Brent Guerisoli views the recently proposed 2.4% pay increase for home health providers in 2027 as a positive signal, indicating a shift towards a more stable reimbursement environment after years of cuts. The company reported strong second-quarter results, with significant increases in home health admissions and hospice revenue, and is progressing with the integration of former Amedisys/UnitedHealth agencies. Pennant also highlighted its investment in Hartford HealthCare at Home, emphasizing expanded patient access and improved clinical outcomes.
Pennant Group acquires River Centre Assisted Living in Tucson, expanding senior living operations.
Pennant Group, Inc. has acquired River Centre Assisted Living, a 63-unit community in Tucson, Arizona, effective August 1, 2026. This acquisition expands Pennant's senior living presence in a growing market, focusing on enhanced personalized care and local leadership. The company plans a seamless transition to support residents and staff while building on the community's existing strengths.
Pennant Group Inc (PNTG) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ...
Pennant Group Inc (PNTG) reported robust Q2 2026 results, with revenue and adjusted EBITDA significantly increasing year-over-year, leading to raised full-year guidance. The company demonstrated strong organic growth in home health and hospice and expanded strategically through acquisitions and partnerships, including an equity investment in Hartford HealthCare at Home. Despite integration challenges with recent acquisitions and increased debt, PNTG is leveraging its local operating model and clinical quality to drive market share and manage industry scrutiny.
Pennant Group (PNTG) Is Down 5.5% After Raising 2026 Outlook and Expanding Senior Living Footprint
Pennant Group (PNTG) recently reported strong Q2 2026 results with increased sales and net income, alongside raised full-year 2026 revenue guidance to US$1.17 billion - US$1.19 billion. The company also expanded its senior living footprint by acquiring River Centre Assisted Living in Tucson, Arizona, reinforcing its community-based care focus. Despite the positive financial updates and strategic expansion, the stock saw a 5.5% decline.
Pennant Group, Inc. SEC Filing (Aug 6, 2026)
This article reports on a Form 144 SEC filing by Pennant Group, Inc. (PNTG) on August 6, 2026. The filing indicates a proposed sale of 1,393 shares of common stock acquired through restricted stock vesting on July 27, 2026, with an aggregate market value of $53,661.84. The document details the filer and issuer information, the securities to be sold, and confirms no previous sales by the individual in the past three months.
Earnings call transcript: Pennant Group beats Q2 2026 estimates, raises outlook
Pennant Group (PNTG) reported better-than-expected Q2 2026 results, with adjusted EPS of $0.36 and revenue of $298.0 million, surpassing analyst estimates. The company raised its full-year 2026 guidance due to strong core operations and successful integration of acquisitions, particularly in the Southeast. Management highlighted significant growth in home health, hospice, and senior living segments, driven by operational excellence and expanding national footprint.
Earnings Flash (PNTG) The Pennant Group, Inc. Posts Q2 Adjusted EPS $0.36 per Share, Vs. FactSet Est of $0.33
The Pennant Group, Inc. (PNTG) reported strong second-quarter results, with adjusted EPS reaching $0.36 per share. This performance exceeded the FactSet estimate of $0.33 per share, indicating better-than-expected profitability for the company.
Pennant Group, Inc. 2026: Revenue $297.98M, EPS $0.25— 10-Q Summary
Pennant Group, Inc. reported strong financial results for the quarter ended 2026, with consolidated revenue reaching $297.98M, marking a 35.8% increase year-over-year, and diluted EPS rising to $0.25. The growth was primarily driven by a significant increase in home health & hospice revenue and operational expansion, including the addition of numerous new agencies and communities. The company also noted potential future impacts from regulatory changes and increased costs from acquisitions.
The Pennant Group (PNTG) Stock Rises on Q2 2026 Earnings
The Pennant Group (PNTG) reported strong Q2 2026 earnings, with revenue up 35.8% to $298.0 million and net income rising to $9.1 million. The positive financial results, including a significant increase in operating cash flow, led to a 3.71% rise in the stock price after market close. Insider trading activity showed sales by the CEO, while institutional investors had mixed movements, and analysts provided a median price target of $42.0.
The Pennant Group (PNTG) Stock Rises on Q2 2026 Earnings
The Pennant Group (PNTG) reported strong Q2 2026 earnings with revenue of $298.0 million, up 35.8% year-over-year, surpassing Wall Street expectations. The company also saw significant growth in operating profit, net income, and operating cash flow, leading to a 3.71% rise in its stock after market close. Insider trading showed sales by the CEO, while institutional holdings saw mixed activity, and analysts set a median price target of $42.0.
The Pennant Group (NASDAQ:PNTG) Delivers Strong Q2 CY2026 Numbers, Full-Year Outlook Slightly Exceeds Expectations
The Pennant Group (NASDAQ:PNTG) reported strong Q2 CY2026 results, exceeding Wall Street's revenue and EPS expectations. The senior living provider saw revenue increase by 37.3% year-on-year to $298 million, with full-year revenue and adjusted EPS guidance also surpassing analyst estimates. Despite strong historical revenue growth, the company's operating margin remains moderate, and shareholder dilution has impacted per-share earnings.
Earnings Flash (PNTG) The Pennant Group, Inc. Reports Q2 Revenue $298.0M, vs. FactSet Est of $288.7M
The Pennant Group, Inc. (PNTG) reported second-quarter revenue of $298.0 million, surpassing FactSet's estimate of $288.7 million. The company's diverse operations include home health, hospice, and senior living services across multiple U.S. states. Analysts currently have a "BUY" consensus rating for PNTG, with an average target price of $45.00.
Earnings Flash (PNTG) The Pennant Group, Inc. Posts Q2 Adjusted EPS $0.36 per Share, vs. FactSet Est of $0.33
The Pennant Group, Inc. (PNTG) reported Q2 adjusted EPS of $0.36 per share, surpassing the FactSet estimate of $0.33. This positive earnings flash also noted the company's Q2 revenue of $298.0 million, which also exceeded the FactSet estimate of $288.7 million. The company has also recently updated its earnings guidance for the year 2026 and made several strategic acquisitions.
Pennant Group (NASDAQ: PNTG) lifts 2026 revenue and EBITDA outlook
The Pennant Group (NASDAQ: PNTG) reported strong second-quarter 2026 results, with total revenue increasing 35.8% year-over-year to $298.0 million and adjusted diluted EPS of $0.36. The company also raised its full-year 2026 guidance for revenue to $1,171.1–$1,190.1 million and adjusted EBITDA to $94.4–$98.0 million, incorporating contributions from recently acquired UnitedHealth and Amedisys assets. This positive outlook is driven by significant growth across its home health, hospice, and senior living segments.
Pennant Group (NASDAQ: PNTG) details Q2 2026 home health and hospice mix
The Pennant Group (NASDAQ: PNTG) reported strong Q2 2026 results, with revenue increasing to $297,984 thousand and diluted EPS rising to $0.25, driven by growth in both home health and hospice, and senior living segments. The company expanded its operations with six new senior living communities and an additional hospice business, but noted increased debt and interest costs. Key regulatory developments, including a nationwide moratorium on new Medicare enrollment for hospices and home health agencies and proposed changes to CMS payment models, were highlighted as potential influences on future operations.
Pennant Group acquires 63-unit assisted living facility in Tucson
The Pennant Group Inc. has acquired the real estate and operations of a 63-unit assisted living community in Tucson, Arizona, which has been renamed River Centre Assisted Living. This acquisition expands Pennant's senior living portfolio, which is operated by its subsidiary Pinnacle Senior Living LLC. The company operates various healthcare services across 17 states.
The Pennant Group, Inc. (PNTG) Tops Q2 Earnings and Revenue Estimates
The Pennant Group, Inc. (PNTG) reported strong Q2 earnings of $0.36 per share, surpassing the Zacks Consensus Estimate of $0.33 and outperforming the previous year's $0.27. The company also exceeded revenue expectations, posting $297.98 million against an estimated $297.98 million. Despite the positive results and a 37.2% year-to-date stock increase, PNTG currently holds a Zacks Rank #3 (Hold) due to mixed estimate revisions.
What To Expect From The Pennant Group’s (PNTG) Q2 Earnings
The Pennant Group (PNTG) is set to report its Q2 earnings, with analysts expecting a 33% year-on-year revenue growth. The company has a history of exceeding Wall Street's expectations, and its stock price has remained unchanged in the last month, despite an average analyst price target suggesting an upside from its current trading price. Peer performance in the senior health segment has been mixed, with BrightSpring Health Services beating expectations but trading down, and Chemed topping estimates and seeing a stock increase.
Pennant Group acquires 63-unit assisted living facility in Tucson By Investing.com
The Pennant Group Inc. (NASDAQ:PNTG) has acquired the real estate and operations of a 63-unit assisted living community in Tucson, Arizona, renaming it River Centre Assisted Living. This acquisition, effective August 1, expands Pennant's senior living portfolio, which operates across 17 states through various healthcare services. Pinnacle Senior Living LLC, a Pennant subsidiary, will manage the new facility.
Tucson’s 63-Unit River Centre Assisted Living Changes Hands
The Pennant Group (NASDAQ: PNTG) announced its acquisition of River Centre Assisted Living, a 63-unit community in Tucson, Arizona, effective August 1, 2026. This acquisition includes both the real estate and operations, aiming to expand Pennant's senior living portfolio in a growing market. The company emphasized continuity of care for residents and a seamless operational transition, maintaining a focus on personalized care and local leadership.
Pennant Acquires River Centre Assisted Living in Tucson, Arizona
The Pennant Group, Inc. (NASDAQ: PNTG) announced the acquisition of the real estate and operations of River Centre Assisted Living in Tucson, Arizona, effective August 1, 2026. This 63-unit assisted living community is expected to enhance Pennant’s senior living operations by focusing on personalized care and local leadership. Pennant aims to integrate the community seamlessly, supporting both residents and employees to ensure continued high-quality care.
The Pennant Group Acquires Inspirations of River Centre Senior Living
The Pennant Group, Inc. announced the acquisition of Inspirations of River Centre Senior Living, now renamed River Centre Assisted Living, effective August 1, 2026. This 63-unit assisted living community in Tucson, Arizona, expands Pennant's senior living operations in a growing market. The company plans to ensure continuity of personalized care and seamless operational integration for residents and families.
What To Expect From The Pennant Group’s (PNTG) Q2 Earnings
The Pennant Group (NASDAQ: PNTG), a senior living provider, is set to report its Q2 earnings this Wednesday after market hours. The company exceeded revenue and EPS expectations last quarter, and analysts anticipate a 33% year-on-year revenue growth for the upcoming quarter. Peer performance in the senior health sector shows mixed results, with BrightSpring Health Services beating revenue estimates but trading down, and Chemed topping estimates and seeing its stock rise.
The Pennant Group, Inc. acquired River Centre Assisted Living.
The Pennant Group, Inc. (NasdaqGS:PNTG) has completed the acquisition of River Centre Assisted Living on August 1, 2026. The company will ensure continuity of care and seamless operational integration during the transition. This acquisition is part of Pennant's strategy to expand its healthcare services.
Vanguard Capital Management (PNTG) discloses 1.74M-share, 5.01% Pennant Group stake
Vanguard Capital Management LLC has filed a Schedule 13G, revealing a passive beneficial ownership of 1,742,207 shares of Pennant Group Inc. common stock, which represents a 5.01% stake as of June 30, 2026. The filing indicates Vanguard has sole voting power over 261,326 shares and sole dispositive power over all 1,742,207 shares, with no shared voting or dispositive authority. This ownership includes securities held by various Vanguard funds and managed accounts.
Pennant Group Number of Employees 2026 | Employee Count & Headcount Data
The Pennant Group, Inc. (PNTG) had approximately 9,702 employees worldwide as of March 2026, marking a 1.4% growth since 2023 but a 1.4% decline year-over-year. The company, headquartered in Eagle, Idaho, and trading on NASDAQ, is actively hiring with 678 job postings in 2026. Its workforce is primarily located in the United States, with Finance and Operations being the largest functional group, and the average salary stands at $71,067.
Pennant Group Inc stock hits 52-week high at 42.58 USD
Pennant Group Inc (PNTG) achieved a new 52-week high of $42.58, pushed by an 84.73% increase over the past year and an impressive 36.76% revenue growth. While the stock's P/E ratio indicates it may be overvalued, four analysts have revised earnings upward, signaling positive sentiment. The company also recently reported strong Q1 2026 financial results and acquired Copper Canyon Memory Care, expanding its senior living operations.
Pennant Group Inc (PNTG) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Pennant Group Inc (PNTG), detailing its current valuation score, P/E ratio, and comparison to recent highs and lows. While the article notes PNTG's P/E ratio of 47.99, it also states that relevant data for P/B, P/S, and P/CF ratios have not yet been disclosed by the company. The company's valuation score is 8.10, ranking it 43 out of 75 in the Healthcare Providers & Services industry.
Pennant Group Q2 Results: Earnings release and call dates set for Aug 5-6
The Pennant Group, Inc. (NASDAQ: PNTG) has scheduled its Q2 2026 earnings release for August 5, 2026, with a live webcast for investors to follow on August 6 at 10:00 a.m. Mountain Time. The company operates home health, hospice, and senior living services through independent subsidiaries across 18 U.S. states. Financial results and SEC Regulation G information will be available on their Investor Relations website.
Pennant Announces Second Quarter 2026 Earnings Release and Call
The Pennant Group, Inc. (NASDAQ: PNTG) announced it will issue its second-quarter 2026 financial results on August 5, 2026. A live webcast will follow on August 6, 2026, at 10:00 a.m. Mountain Time, where management will discuss the results. Interested parties can access the webcast and related financial information on the company's investor relations website.
Pennant expects Q2 results Aug. 5; webcast follows Aug. 6
The Pennant Group (NASDAQ: PNTG) announced it will release its second quarter 2026 financial results on Wednesday, August 5, 2026. Following the release, a live webcast with management to discuss the results will be held on Thursday, August 6, 2026, at 10:00 a.m. Mountain Time. Investors can access the webcast and related financial information through the company's investor relations website, with a replay available until August 6, 2027.
PNTG|Pennant Group Inc|Price:41.160|Chg%:+1.350
The Pennant Group, Inc. (PNTG) provides healthcare services through home health and hospice agencies and senior living communities across numerous states. The article details the company's structure, executive team, and key financial information. As of Q1 2026, institutional shareholding increased, and Medicare business was the largest revenue generator.
PNTG|Pennant Group Inc|Price:41.160|Chg%:+1.350
Pennant Group Inc. (PNTG) is trading at $41.160, up 3.39%, with high growth potential and stable fundamentals. The company operates home health, hospice, and senior living services across multiple states, and its stock is rated as a "Strong Buy" by analysts with a target price of $43.50. Despite strong market performance, technical indicators suggest range-bound trading.
The Pennant Group, Inc. (PNTG) Stock Analysis: Is A 9.36% Upside Within Reach?
The Pennant Group, Inc. (PNTG) is presented as an intriguing investment prospect in the healthcare sector, backed by strong financial performance and analyst optimism. Analysts have issued seven buy ratings with an average target price of $45.00, suggesting a potential upside of 9.36%. The company's robust revenue growth, solid cash flow, and strong technical indicators further strengthen its investment case.
How The Pennant Group Inc. (PNTG) Affects Rotational Strategy Timing
This article analyzes The Pennant Group Inc. (PNTG) through a quantitative research lens, highlighting strong sentiment across all horizons supporting an overweight bias. It outlines three institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones. The analysis also provides multi-timeframe signal strengths with corresponding support and resistance levels for near-term, mid-term, and long-term horizons, driven by AI-generated signals.
